The scientific emphasis of this proposal is to determine the role that pancreatic cancer associated fibroblasts (CAFs) play in tumor evolution using novel mouse modeling and functional in vitro assays. The pancreatic tumor microenvironment - which makes up over half of the tumor volume - is known to play an important role in tumor development and drug resistance. The hedgehog paracrine loop between epithelial and stromal cells has been widely discussed in the literature and its mis-regualtion in cancer has recently become evident. Briefly, tumor cells secrete hedgehog ligands that activate surrounding stromal fibroblasts, thus leading to their secretion of pro-tumor factors In this project, we aim to study the effect of disrupting this feedback loop by deleting a key hedgehog ligand receptor in stromal fibroblasts. Specifically, using novel mouse models developed in our lab, we show that conditionally deleting the hedgehog ligand receptor smoothened (Smo) exclusively in the fibroblast compartment leads to accelerated Kras-driven tumorigenesis. Thus, we have discovered a novel tumor suppressive role for SMO in pancreatic fibroblasts and this project will further characterize the pro-tumor mechanisms upon deletion of Smo in pancreatic CAFs. Additionally, this result provides some rationale for the recent failure of SMO inhibitor clinical trials in pancreatic cancer patients. Furthering the understanding of pro-tumor mechanisms in Smonull fibroblasts will provide key insight into why these trials have failed and potentially offer new therapeutic avenues. Through experiments described in this proposal, we will study alterations in tumor development over time and characterize the effects of deleting Smo in pancreatic fibroblasts using in vivo mouse modeling.

Public Health Relevance

Pancreatic cancer is one of the most deadly cancers over the last 35 years, with less than 6% of patients surviving 5-years after diagnosis. Over the last ten years it has become apparent that the non-cancerous cells that surround the tumor play a driver role in the fate of the tumor cell. Understanding how these cells interact with adjacent tumor cells will lead to novel therapeutic strategies to prolong survival in this deadly disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31CA189757-01A1
Application #
8908533
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Schmidt, Michael K
Project Start
2015-05-01
Project End
2016-04-30
Budget Start
2015-05-01
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Ohio State University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Pitarresi, Jason R; Liu, Xin; Avendano, Alex et al. (2018) Disruption of stromal hedgehog signaling initiates RNF5-mediated proteasomal degradation of PTEN and accelerates pancreatic tumor growth. Life Sci Alliance 1:e201800190
Sizemore, Gina M; Pitarresi, Jason R; Balakrishnan, Subhasree et al. (2017) The ETS family of oncogenic transcription factors in solid tumours. Nat Rev Cancer 17:337-351
Liu, Xin; Pitarresi, Jason R; CuitiƱo, Maria C et al. (2016) Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar-ductal metaplasia. Genes Dev 30:1943-55
Pitarresi, Jason R; Liu, Xin; Sharma, Sudarshana M et al. (2016) Stromal ETS2 Regulates Chemokine Production and Immune Cell Recruitment during Acinar-to-Ductal Metaplasia. Neoplasia 18:541-52